More articles from Companion Diagnostic, Pharmacogenomic, and Cancer Biomarkers

Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
Heather M. Moore, Heidi M. Savage, Carol O'Brien, Wei Zhou, Ethan S. Sokol, Michael E. Goldberg, Ciara Metcalfe, Lori S. Friedman, Mark R. Lackner, Timothy R. Wilson

Molecular Cancer Therapeutics Jan 2020, 19 (1) 292-303; DOI: 10.1158/1535-7163.MCT-19-0284
Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates
Usha Malhotra, Sarbajit Mukherjee, Christos Fountzilas, Patrick Boland, Austin Miller, Santosh Patnaik, Kristopher Attwood, Sai Yendamuri, Araba Adjei, Eric Kannisto, Mateusz Opyrchal, Peter Bushunow, Peter Loud, Renuka Iyer, Nikhil Khushalani

Molecular Cancer Therapeutics Jan 2020, 19 (1) 304-311; DOI: 10.1158/1535-7163.MCT-19-0240
ADP-Ribosylation Levels and Patterns Correlate with Gene Expression and Clinical Outcomes in Ovarian Cancers
Lesley B. Conrad, Ken Y. Lin, Tulip Nandu, Bryan A. Gibson, Jayanthi S. Lea, W. Lee Kraus

Molecular Cancer Therapeutics Jan 2020, 19 (1) 282-291; DOI: 10.1158/1535-7163.MCT-19-0569
Identification of Expression Profiles Defining Distinct Prognostic Subsets of Radioactive-Iodine Refractory Differentiated Thyroid Cancer from the DECISION Trial
Jaume Capdevila, Ignacio Matos, Francesco M. Mancuso, Carmela Iglesias, Paolo Nuciforo, Carles Zafon, Hector G. Palmer, Zighereda Ogbah, Laura Muiños, Jorge Hernando, Guillermo Villacampa, Carol E. Peña, Josep Tabernero, Marcia S. Brose, Martin Schlumberger, Ana Vivancos

Molecular Cancer Therapeutics Jan 2020, 19 (1) 312-317; DOI: 10.1158/1535-7163.MCT-19-0211
Serum PD-1 Is Elevated after Pembrolizumab Treatment but Has No Predictive Value
Milena Music, Marco A.J. Iafolla, Annie He Ren, Antoninus Soosaipillai, Ioannis Prassas, Eleftherios P. Diamandis

Molecular Cancer Therapeutics Oct 2019, 18 (10) 1844-1851; DOI: 10.1158/1535-7163.MCT-19-0132
Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics
In Sil Choi, Shumei Kato, Paul T. Fanta, Lawrence Leichman, Ryosuke Okamura, Victoria M. Raymond, Richard B. Lanman, Scott M. Lippman, Razelle Kurzrock

Molecular Cancer Therapeutics Oct 2019, 18 (10) 1852-1862; DOI: 10.1158/1535-7163.MCT-18-0965
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia
Dimitrios Papaioannou, Deedra Nicolet, Hatice G. Ozer, Krzysztof Mrózek, Stefano Volinia, Paolo Fadda, Andrew J. Carroll, Jessica Kohlschmidt, Jonathan E. Kolitz, Eunice S. Wang, Richard M. Stone, John C. Byrd, Ramiro Garzon, Clara D. Bloomfield

Molecular Cancer Therapeutics Aug 2019, 18 (8) 1451-1459; DOI: 10.1158/1535-7163.MCT-18-1125
Genotyping of Circulating Tumor DNA Reveals the Clinically Actionable Mutation Landscape of Advanced Colorectal Cancer
Weiguo Cao, Yaping Xu, Lianpeng Chang, Yuhua Gong, Liren Li, Xianwei Mo, Xin Zhang, Guole Lin, Jiaolin Zhou, Dan Liu, Yuting Yi, Pingping Dai, Chenchen Zhu, Tao Liu, Yuxing Chu, Yanfang Guan, Yongsheng Chen, Jiayin Wang, Xuefeng Xia, Ling Yang, Xin Yi, Yong Cheng

Molecular Cancer Therapeutics Jun 2019, 18 (6) 1158-1167; DOI: 10.1158/1535-7163.MCT-18-1247
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis
Filip Janku, Eli L. Diamond, Aaron M. Goodman, Vaijayanthi Kandadai Raghavan, Tamara G. Barnes, Shumei Kato, Omar Abdel-Wahab, Benjamin H. Durham, Funda Meric-Bernstam, Razelle Kurzrock

Molecular Cancer Therapeutics Jun 2019, 18 (6) 1149-1157; DOI: 10.1158/1535-7163.MCT-18-1244
Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies
Rebecca Shatsky, Barbara A. Parker, Nam Q. Bui, Teresa Helsten, Richard B. Schwab, Sarah G Boles, Razelle Kurzrock

Molecular Cancer Therapeutics May 2019, 18 (5) 1001-1011; DOI: 10.1158/1535-7163.MCT-17-1038

Main menu

User menu

Search

More articles from Companion Diagnostic, Pharmacogenomic, and Cancer Biomarkers

Pages

Articles

Info for

About MCT